Average Co-Inventor Count = 3.89
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (24 from 4,442 patents)
2. Emisphere Technologies, Inc. (5 from 183 patents)
29 patents:
1. 9776992 - 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers
2. 8765796 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
3. 8552039 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
4. 8546581 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
5. 7947841 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
6. 7662771 - Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
7. 7125840 - Substituted dipeptides as growth hormone secretagogues
8. 7101891 - Compounds and pharmaceutical compositions for inhibiting MRP1
9. 7037921 - Compounds and methods for inhibiting MRP1
10. 6992097 - Growth hormone secretagogues
11. 6743794 - Methods and compounds for inhibiting MRP1
12. 6686372 - Selective &bgr;3 adrenergic agonists
13. 6639076 - Growth hormone secretagogues
14. 6440958 - Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods
15. 6413991 - Selective &bgr;3 adrenergic agonists